Sub programme: Oresund

Lead Partner: Öresundsuniversitetet/Lunds Universitet

Partners: UMAS Malmö (Reproduktionsmedicinskt Centrum samt Urologiska Kliniken), Lund University, Herlev Hospital, Rigshospitalet, University of Copenhagen, Bispebjerg Hospital.

Project Period: 1 March 2010 - 28 Feb 2013[The project is completed]

Total Budget: 1 785 080

Udbetalt støtte fra ERUF: 892 540 EUR

Kontakt: Aleksander Giwercman


Phone: + 46 40338282

To many people, starting a family is a natural part of a normal life. However, 15 percent of the couples in the Oresund Region aren’t able to have children. The project Reprosund wanted to provide infertile couples with the best treatment from both sides of the Oresund.

Unequal options
One out of six couples experience not being able to have children. Infertility is a serious, medical, social, and financial problem for the couples it affects. However, doctors know little about the causes of infertility and symptoms are often treated instead of the cause.

When it comes to infertility, Sweden and Denmark have acquired skills within different areas of research. However, research from e.g. Denmark cannot help couples from Sweden and vice versa due to great barriers between the two healthcare systems. Therefore, the project Reprosund worked to secure an equal and optimal treatment to all infertile couples in the Oresund Region; wherever it be.

Cooperation provided better treatment
The project wanted to spread knowledge about infertility to the population, to patients, scientists, and medical staff. Thus, the project started fertility counseling clinics in Copenhagen and Malmö - with free counselling.

Also, the project mapped the best treament facilities in the region. However, this was only the first step. At the end of the project period, the project succeeded in arranging a deal between Denmark and Sweden that made it possible for infertile people to get treatment on the other side of the border.

Reprosund evolves into Reprohigh
The project ended in February 2013. At this point in time however, no people had actually recieved treatment across the border. Thus, the project applied for fundings for a new project, Reprohigh, which was approved by Interreg and started shortly after.

Read more about Reprohigh here.


Aleksander Giwercman

+ 46 40338282